Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
McKesson
Colorcon
Baxter
Dow

Last Updated: May 25, 2022

CLINICAL TRIALS PROFILE FOR NALTREXONE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Naltrexone Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000195 ↗ Neurobiology of Opioid Dependence: 4 - 4 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 1993-01-01 The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
NCT00000195 ↗ Neurobiology of Opioid Dependence: 4 - 4 Withdrawn Yale University Phase 2 1993-01-01 The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
NCT00000196 ↗ Neurobiology of Opioid Dependence: 5 - 5 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 1993-01-01 The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
NCT00000196 ↗ Neurobiology of Opioid Dependence: 5 - 5 Withdrawn Yale University Phase 2 1993-01-01 The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
NCT00000230 ↗ Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 Completed National Institute on Drug Abuse (NIDA) Phase 2 1995-01-01 The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with naltrexone.
NCT00000230 ↗ Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 Completed University of Vermont Phase 2 1995-01-01 The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with naltrexone.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Naltrexone Hydrochloride

Condition Name

Condition Name for Naltrexone Hydrochloride
Intervention Trials
Alcoholism 55
Alcohol Dependence 49
Obesity 27
Opioid-Related Disorders 20
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Naltrexone Hydrochloride
Intervention Trials
Alcoholism 120
Opioid-Related Disorders 91
Disease 49
Substance-Related Disorders 31
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Naltrexone Hydrochloride

Trials by Country

Trials by Country for Naltrexone Hydrochloride
Location Trials
United States 771
Canada 14
Germany 13
China 12
Russian Federation 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Naltrexone Hydrochloride
Location Trials
New York 68
Connecticut 57
California 52
Pennsylvania 50
Florida 36
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Naltrexone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Naltrexone Hydrochloride
Clinical Trial Phase Trials
Phase 4 99
Phase 3 59
Phase 2/Phase 3 36
[disabled in preview] 213
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Naltrexone Hydrochloride
Clinical Trial Phase Trials
Completed 302
Recruiting 52
Not yet recruiting 33
[disabled in preview] 49
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Naltrexone Hydrochloride

Sponsor Name

Sponsor Name for Naltrexone Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 94
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 60
Yale University 37
[disabled in preview] 79
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Naltrexone Hydrochloride
Sponsor Trials
Other 494
NIH 176
Industry 126
[disabled in preview] 25
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKesson
Boehringer Ingelheim
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.